Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A systematic program to test incarcerated Americans for hepatitis C and treat those who are infected would be highly cost-effective.
The Centers for Disease Control and Prevention?s (CDC) monitoring of acute, or very early, hepatitis C cases is woefully inadequate.
In most cases, Harvoni is cost effective when compared with older hepatitis C treatments, but treating all of those in need will be highly exp...
Sovaldi (sofosbuvir) is a cost-effective treatment option for hepatitis C among the prison population when compared with other options.
Thanks to new, highly effective treatments and increased screening, hepatitis C could become a rare disease in 22 years, according to a modeli...
Experts also called into question how many people would actually have access to new, expensive life-saving therapies.
The U.S. Preventive Services Task Force has recommended screening for those at high risk of hepatitis B infection, including those with HIV.
Reducing its estimate of hepatitis C prevalence from 3.2 to 2.7 million, the CDC calculated that four in five cases are among baby boomers.
Fibrosis in those coinfected with hepatitis C and HIV is comparable in severity to that found in people mono- infected with hep C who are near...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.